AstraZeneca denies 'lying' over Losec patents in ECJ appeal of antitrust fine
AstraZeneca today told the EU's Court of Justice that the European Commission had misunderstood the use of anti-ulcer drugs and marketing authorisations when it sanctioned the pharma giant for misleading patent...To view the full article, register now.
Already a subscriber? Click here to view full article